Results 31 to 40 of about 14,154 (120)

Prevalence of drug resistance against NRTI, NNRTI and PI.

open access: yes, 2023
Abbreviations: PI; atazanavir/ritonavir (ATV/r), darunavir/ ritonavir (DRV/r), fosamprenavir/ ritonavir (FPV/r), indinavir/ ritonavir (IDV/r), lopinavir/ ritonavir (LPV/r), nelfinavir (NFV), tipranavir/ ritonavir (TPV/r). NRTI; stavudin (d4T), didanosin (
Dilsha Siddiqui (16877717)   +10 more
core   +1 more source

Stability of the HIV cascade of care throughout the COVID‐19 pandemic in Europe: Results from the multinational EuroSIDA cohort study (2016–2022)

open access: yesHIV Medicine, Volume 27, Issue 11, Page 1832-1844, November 2026.
Abstract Background Prior to the COVID‐19 pandemic, antiretroviral therapy (ART) coverage and viral suppression were improving across Europe; however, the impact of the pandemic on HIV care remains uncertain. Methods In‐person visits, ART coverage and viral suppression among those on ART were described in the EuroSIDA cohort for each calendar year from
Olga Fursa   +18 more
wiley   +1 more source

Prevalence of major NRTI and NNRTI resistance mutations in individuals with acquired drug resistance.

open access: yes, 2016
Absolute and cumulative prevalence of each major nucleoside (NRTI) and nonnucleoside RT inhibitor (NNRTI) drug-resistance mutation (DRM) in 4,926 individuals with virological failure and intermediate or high-level acquired NRTI or NNRTI resistance while ...
Neil Parkin (273844)   +31 more
core   +1 more source

Medicinal Chemistry Aspects of Thiazole and Thiazolidine Derivatives as Fundamental Building Blocks to Design New NNRTIs Against HIV‐1 Reverse Transcriptase

open access: yesChemMedChem, Volume 21, Issue 19, 14 October 2026.
HIV‐1 reverse transcriptase (HIV‐1 RT) is a polymerase enzyme and a key target in HIV‐1 therapy. The discovery of selective HIV‐1 RT inhibitors has highlighted thiazole scaffolds and their derivatives, thiazolidine‐2‐one and thiazolidine‐2,4‐dione, as promising structures for the rational design of novel non‐nucleoside reverse transcriptase inhibitors (
José Arion da Silva Moura   +9 more
wiley   +1 more source

Prevalence of nucleoside reverse transcriptase inhibitor (NRTI) and non-nucleoside reverse transcriptase inhibitor (NNRTI) mutations.

open access: yes, 2019
Prevalence of nucleoside reverse transcriptase inhibitor (NRTI) and non-nucleoside reverse transcriptase inhibitor (NNRTI) mutations.
Damian Nota Anong (4911604)   +6 more
core   +1 more source

Predictors of Liver Steatosis Progression Among People Living With HIV in Low‐ and Middle‐Income Countries: A Multicentre Longitudinal Study

open access: yesJournal of the International AIDS Society, Volume 29, Issue 10, October 2026.
ABSTRACT Introduction Liver steatosis is increasingly recognized as a major comorbidity in people living with HIV (PLWH), with growing evidence suggesting an increased risk of progression to advanced liver disease. We assessed predictors of liver steatosis progression over 36 months in PLWH from low‐ and middle‐income countries.
Marie K. Plaisy   +27 more
wiley   +1 more source

Metabolic Dysfunction‐Associated Steatohepatitis and the Progression of Cognitive Decline in Older Thai People With HIV

open access: yesJournal of the International AIDS Society, Volume 29, Issue 10, October 2026.
ABSTRACT Introduction Metabolic dysfunction‐associated steatohepatitis (MASH) is more common in people with HIV and associated with systemic inflammation and extrahepatic complications, including cognitive impairment. While cross‐sectional studies suggest an association between MASH and worse cognitive outcomes, its impact on longitudinal cognitive ...
Katekarn Porkaew   +7 more
wiley   +1 more source

Market share of selected antiretrovirals of the nRTI-class (% of all treatment days per year).

open access: yes, 2013
Market share of selected antiretrovirals of the nRTI-class (% of all treatment days per year).
Stefan Reuter (199795)   +14 more
core   +1 more source

Association Between HIV Infection Duration and Left Ventricular Concentric Remodeling and Myocardial Fibrosis: A Cross‐Sectional Study Using Cardiac MRI

open access: yesJournal of Magnetic Resonance Imaging, Volume 64, Issue 4, Page 1037-1049, October 2026.
ABSTRACT Background Antiretroviral therapy has transformed HIV into a chronic condition, yet cardiac injury remains a major issue. Purpose To assess the ability of cardiac MR imaging markers to predict cardiac injury and disease progression in HIV‐infected individuals. Study Type Prospective.
Chunyan Deng   +5 more
wiley   +1 more source

Dynamics of NRTI resistance mutations during therapy interruption

open access: yes, 2009
To date, very little information is available regarding the evolution of drug resistance mutations during treatment interruption (TI). Using a survival analysis approach, we investigated the dynamics of mutations associated with resistance to nucleoside ...
Tortta, M.   +52 more
core   +1 more source

Home - About - Disclaimer - Privacy